Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.
Antimüllerian hormone (AMH) and other markers of ovarian reserve were assessed to determine their predictive value with respect to treatment outcome. In a multivariate regression analysis, AMH was found to be predictive of the number of oocytes and the number of embryos, but not of embryo quality or the chance of a pregnancy, after IVF/ICSI.
Smeenk
Jesper M J
JM
Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands. j.smeenk@obgyn.umcn.nl <j.smeenk@obgyn.umcn.nl>
Sweep
Fred C G J
FC
Zielhuis
Gerhard A
GA
Kremer
Jan A M
JA
Thomas
Chris M G
CM
Braat
Didi D M
DD
D000328:Adult; D054304:Anti-Mullerian Hormone; D015415:Biomarkers / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D007247:Infertility, Female / Q000097:blood* / Q000175:diagnosis / Q000628:therapy*; D010062:Ovulation Induction; D011247:Pregnancy; D011256:Pregnancy Outcome; D011379:Prognosis; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D020554:Sperm Injections, Intracytoplasmic / Q000379:methods*; D013735:Testicular Hormones / Q000097:blood*; D016896:Treatment Outcome
D015415:Biomarkers; D006023:Glycoproteins; D013735:Testicular Hormones; D054304:Anti-Mullerian Hormone